| Ticker Details |
Omnicell, Inc.
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
|
| IPO Date: |
August 7, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Technology |
| Market Cap: |
$1.81B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.62 | 1.68%
|
| Avg Daily Range (30 D): |
$0.84 | 1.94%
|
| Avg Daily Range (90 D): |
$0.69 | 1.73%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.29M |
| Avg Daily Volume (30 D): |
.57M |
| Avg Daily Volume (90 D): |
.45M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
46 |
| Avg Trade Size (Sh.) (90 D): |
44 |
| Institutional Trades |
| Total Institutional Trades: |
6,271 |
| Avg Institutional Trade: |
$2.62M |
| Avg Institutional Trade (30 D): |
$2.25M |
| Avg Institutional Trade (90 D): |
$2.2M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.35M |
| Avg Closing Trade (30 D): |
$3.65M |
| Avg Closing Trade (90 D): |
$3.45M |
| Avg Closing Volume: |
55.21K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.43
|
$.12
|
$.12
|
|
Diluted EPS
|
$.43
|
$.12
|
$.12
|
|
Revenue
|
$1.18B
|
$310.63M
|
$290.56M
|
|
Gross Profit
|
$514.88M
|
$134.5M
|
$127.68M
|
|
Net Income / Loss
|
$19.92M
|
$5.46M
|
$5.64M
|
|
Operating Income / Loss
|
$17.14M
|
$8.24M
|
$8.12M
|
|
Cost of Revenue
|
$662.86M
|
$176.13M
|
$162.88M
|
|
Net Cash Flow
|
$-367.44M
|
$-206.05M
|
$17.1M
|
|
PE Ratio
|
93.37
|
|
|
|
|
|